34 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
. Insurance. The Company may, at its discretion, apply for and procure in its own name and for its own benefit life and/or disability insurance
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
but for injury, ill health, disability, pregnancy, childbirth, maternity, paternity or parental leave, reasonable holiday entitlement or not being … Holder holding a Nominal-Cost Option ceases to be Connected for one of the following reasons:
death;
disability, injury or ill health (evidenced
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
the employee would have been required to so spend but for injury, ill health, disability, pregnancy, childbirth, maternity, paternity or parental leave … ceases to be Connected for one of the following reasons:
death;
disability, injury or ill health (evidenced to the satisfaction of the Board
8-K
EX-10.1
qy2p4pk9 seile
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.01
syaufszdkux
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.1
262x0
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
rhex78
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
EX-10.1
6xdq5n
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
gdezz
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.1
fxstartmvv
27 Jun 19
Departure of Directors or Certain Officers
8:08am